DRA

Vantaa, Finland Founded: 2002 • Age: 24 yrs Acquired By PharmaLex
Market access services are provided to the biopharma sector.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About DRA

DRA is a company based in Vantaa (Finland) founded in 2002 was acquired by PharmaLex in August 2022. DRA offers products and services including Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services. DRA operates in a competitive market with competitors including OPEN Health, Target RWE, Abacus Medicine, Secura Bio and STATinMED Research, among others.

  • Headquarter Vantaa, Finland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pharmalex Gmbh
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    PharmaLex

    (Aug 26, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DRA

DRA offers a comprehensive portfolio of products and services, including Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services.

Primary

Provides strategic advice for pharmaceutical development and innovation.

Manages adverse event monitoring and risk assessment in healthcare.

Handles regulatory writing and agency interactions for approvals.

Funding Insights of DRA

Investors in DRA

DRA has secured backing from 1 investor. Prominent investors backing the company include PharmaLex.

All
Investor Description Founded Year Domain Location
CRO specializing in regulatory affairs and pharmacovigilance
Founded Year Domain Location

Investments & Acquisitions by DRA

Investments

Financial Statements - DRA

Dra Comparisons

+
Add Comparison
Available on Premium

Competitors of DRA

DRA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Abacus Medicine, Secura Bio and STATinMED Research, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of healthcare marketing services
domain founded_year HQ Location
Marketing services to the pharmaceutical industry are provided.
domain founded_year HQ Location
Consulting services for market access, health economics and outcomes research
domain founded_year HQ Location
Consulting services for market access and health outcomes are provided.
domain founded_year HQ Location
Healthcare data analytics services provider
domain founded_year HQ Location
Offers business insurance, employee benefits, and risk consulting services worldwide.

Latest news on Dra

Frequently Asked Questions about DRA

DRA was founded in 2002.

DRA is headquartered in Vantaa, Finland.

DRA was established in 2002 and is based in Vantaa, Finland. Market access services are delivered to companies in the biopharma industry. Operations focus on supporting product launches, pricing strategies, and reimbursement processes. Expertise is applied across European markets, with emphasis on regulatory compliance and stakeholder engagement. The domain dra.fi serves as the primary online presence for these activities.

DRA's top competitors include OPEN Health, Abacus Medicine and Target RWE.

DRA offers Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services.

DRA has 1 investor. Key investors include PharmaLex.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available